NLRP3 and cancer: In this study, the results of CCK-8 assay show that MNS can inhibit the proliferation of SW1990 and PANC-1 cells but had no obvious influence on ex vivo prepared CIK cells, indicating that simultaneous application of NLRP3 inflammasome inhibition and CIK cell infusion is preferable for cancer treatment.